- Joined
- Jan 4, 2005
- Messages
- 779
- Reaction score
- 3
Article in Annals this month:
Etomidate Versus Midazolam for Procedural Sedation in Pediatric Outpatients: A Randomized Controlled Trial
Liddo, et al.,
Ann Emerg Med 2006;48:433-440.
In brief, a randomized, double-blind study of 100 kids in an orthopedic clinic based trial who were sedated for displaced extremity fractures.
All got 1 mcg/kg fentanyl plus either 0.2 mg/kg etomidate or 0.1 mg/kg medazolam.
Etomidate had significantly quicker induction and recovery time, both had a similar side effect of desaturation (around 10% in both groups).
The "cost" of the quicker onset and recovery time was increased pain at injection site (46 vs. 12% in the etomidate group) and myoclonus occurred in 20% of the etomidate group but none with the versed.
There were limitations, too, like the fact that once a kid gets myoclonus, the person recording recovery time isn't really blinded anymore... but putting aside this and other limitations of the paper, my question is this:
If a kid has myoclonus, is this gonna prevent me from getting an MRI or CT which might be the reason I sedated the little chigger in the first place?? Or is it likely to be so transient that it won't matter?
For the record, the authors rightly pointed out that it would still be nice to see a large series to better establish the safety profile of etomidate as well as a randomized trial comparing relative efficacy and safety of etomidate, propofol, and ketamine.
Etomidate Versus Midazolam for Procedural Sedation in Pediatric Outpatients: A Randomized Controlled Trial
Liddo, et al.,
Ann Emerg Med 2006;48:433-440.
In brief, a randomized, double-blind study of 100 kids in an orthopedic clinic based trial who were sedated for displaced extremity fractures.
All got 1 mcg/kg fentanyl plus either 0.2 mg/kg etomidate or 0.1 mg/kg medazolam.
Etomidate had significantly quicker induction and recovery time, both had a similar side effect of desaturation (around 10% in both groups).
The "cost" of the quicker onset and recovery time was increased pain at injection site (46 vs. 12% in the etomidate group) and myoclonus occurred in 20% of the etomidate group but none with the versed.
There were limitations, too, like the fact that once a kid gets myoclonus, the person recording recovery time isn't really blinded anymore... but putting aside this and other limitations of the paper, my question is this:
If a kid has myoclonus, is this gonna prevent me from getting an MRI or CT which might be the reason I sedated the little chigger in the first place?? Or is it likely to be so transient that it won't matter?
For the record, the authors rightly pointed out that it would still be nice to see a large series to better establish the safety profile of etomidate as well as a randomized trial comparing relative efficacy and safety of etomidate, propofol, and ketamine.